Trial intelligence / Profile preview

Aorto-femoral Bypass vs Stenting in Iliac Occlusive Disease

NCT02209350Phase 1Completed

Sponsor
E. Meshalkin National Medical Research Centre
Start
Aug 2015
Primary completion
Nov 2020
Countries
1
01

Overview

Phase 1, randomised, open-label trial (2 arms), sponsored by E. Meshalkin National Medical Research Centre. Primary endpoints: Technical success at 1 day, 30-day complication rate and 2 more. Started Aug 2015; status: completed.

Beyond the preview

Go deeper on NCT02209350.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02209350.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call